Published in JAMA on January 23, 2008
A Diabetes Improvement in Medical Therapy Versus SADJB Study (DIMS) | NCT03165812
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med (2012) 13.59
Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med (2009) 8.06
Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA (2010) 5.77
The metabolic syndrome. Endocr Rev (2008) 5.33
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ (2013) 5.08
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial. JAMA Surg (2015) 3.67
How do we define cure of diabetes? Diabetes Care (2009) 3.59
Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA (2013) 3.57
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med (2017) 3.53
Bariatric surgery for obesity and metabolic conditions in adults. BMJ (2014) 3.22
Health benefits of gastric bypass surgery after 6 years. JAMA (2012) 3.10
A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg (2013) 3.06
Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med (2011) 2.74
Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) (2009) 2.70
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) (2009) 2.28
The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab (2008) 2.27
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) (2013) 2.22
Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery. Lancet Diabetes Endocrinol (2014) 2.16
Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care (2012) 2.08
Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care (2009) 2.04
Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care (2009) 2.00
Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg (2013) 1.91
Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis (2009) 1.88
Bariatric surgery reduces visceral adipose inflammation and improves endothelial function in type 2 diabetic mice. Arterioscler Thromb Vasc Biol (2011) 1.69
Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care (2012) 1.66
Expectations for weight loss and willingness to accept risk among patients seeking weight loss surgery. JAMA Surg (2013) 1.66
Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol (2015) 1.64
Mechanism for improved insulin sensitivity after gastric bypass surgery. J Clin Endocrinol Metab (2008) 1.62
Bariatric Surgery can Lead to Net Cost Savings to Health Care Systems: Results from a Comprehensive European Decision Analytic Model. Obes Surg (2015) 1.60
Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med (2010) 1.54
Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care. PLoS Med (2015) 1.50
Bariatric surgery and diabetes: who should be offered the option of remission? JAMA (2009) 1.48
Gut feelings about diabetes. Endocrinol Nutr (2012) 1.46
Bariatric surgery: a systematic review of the clinical and economic evidence. J Gen Intern Med (2011) 1.45
Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? Obes Surg (2008) 1.45
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism (2011) 1.41
Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care (2009) 1.41
Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg (2014) 1.41
Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg (2014) 1.40
Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol (2010) 1.37
Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol (2010) 1.37
An electronic health record-enabled obesity database. BMC Med Inform Decis Mak (2012) 1.36
Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33
Do we really know why diabetes remits after gastric bypass surgery? Endocrine (2011) 1.32
Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring) (2009) 1.29
Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care (2010) 1.25
Comparison of combined aerobic and high-force eccentric resistance exercise with aerobic exercise only for people with type 2 diabetes mellitus. Phys Ther (2008) 1.25
Bariatric surgery. Dtsch Arztebl Int (2011) 1.23
Exercise following bariatric surgery: systematic review. Obes Surg (2010) 1.21
Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care (2011) 1.21
Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology (2008) 1.19
Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI ≥35 kg/m². Obesity (Silver Spring) (2010) 1.19
Gastrointestinal surgery as a treatment for diabetes. JAMA (2008) 1.18
Incidence and prevalence of copper deficiency following roux-en-y gastric bypass surgery. Int J Obes (Lond) (2011) 1.14
Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle. Arch Surg (2011) 1.14
Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg (2014) 1.12
Evidence-based German guidelines for surgery for obesity. Int J Colorectal Dis (2011) 1.12
Sex, race, and consideration of bariatric surgery among primary care patients with moderate to severe obesity. J Gen Intern Med (2013) 1.10
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care (2015) 1.10
Laparoscopic single-site surgery for placement of an adjustable gastric band: initial experience. Surg Endosc (2009) 1.10
Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia (2016) 1.09
The outliers become a stampede as immunometabolism reaches a tipping point. Immunol Rev (2012) 1.08
Impact of bariatric surgery on life expectancy in severely obese patients with diabetes: a decision analysis. Ann Surg (2015) 1.08
Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk. Vasc Health Risk Manag (2010) 1.07
Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J Obes (2013) 1.07
Type 2 diabetes: etiology and reversibility. Diabetes Care (2013) 1.06
The great debate: medicine or surgery: what is best for the patient with type 2 diabetes? Diabetes Care (2011) 1.06
Nonalcoholic fatty liver disease and the coronary artery disease. Dig Dis Sci (2010) 1.05
Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes (2014) 1.05
Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity. Br J Gen Pract (2013) 1.04
Metabolic surgery for type 2 diabetes. Nat Med (2012) 1.03
The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale. BMC Health Serv Res (2010) 1.03
Laparoscopic adjustable gastric banding (LAGB): surgical results and 5-year follow-up. Surg Endosc (2010) 1.02
Plasticity of central autonomic neural circuits in diabetes. Biochim Biophys Acta (2008) 1.01
Expansion and contraction: treating diabetes with bariatric surgery. Nat Med (2009) 1.01
Short-term overeating induces insulin resistance in fat cells in lean human subjects. Mol Med (2009) 1.00
Morbid obesity in pediatric diabetes mellitus: surgical options and outcomes. Nat Rev Endocrinol (2010) 1.00
Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab (2010) 1.00
Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery. Obesity (Silver Spring) (2010) 0.99
Attitudes about the safety and efficacy of bariatric surgery among patients with type 2 diabetes and a body mass index of 30-40 kg/m2. Surg Obes Relat Dis (2012) 0.98
Physicians' attitudes about referring their type 2 diabetes patients for bariatric surgery. Surg Obes Relat Dis (2012) 0.98
Type 2 diabetes mellitus--current therapies and the emergence of surgical options. Nat Rev Endocrinol (2011) 0.97
Mineral malnutrition following bariatric surgery. Adv Nutr (2013) 0.97
Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes (2013) 0.97
Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract (2013) 0.97
Effect of gastric bypass surgery on the incretins. Diabetes Metab (2009) 0.96
Past, present, and future: Critical analysis of use of gastric bands in obese patients. Diabetes Metab Syndr Obes (2010) 0.96
Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond) (2011) 0.96
Newer antidiabetic drugs and calorie restriction mimicry. Indian J Endocrinol Metab (2016) 0.96
Demographics and outcomes at American Society for Metabolic and Bariatric Surgery Centers of Excellence. Surg Endosc (2009) 0.94
Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer. Cardiorenal Med (2012) 0.94
Goal-directed resuscitation for patients with early septic shock. N Engl J Med (2014) 11.32
Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med (2009) 10.60
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA (2009) 9.47
Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA (2012) 8.05
Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med (2015) 7.73
Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med (2006) 5.54
Long-term persistence of hormonal adaptations to weight loss. N Engl J Med (2011) 5.51
Insulin levels in insulin resistance: phantom of the metabolic opera? Med J Aust (2006) 5.33
Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med (2012) 5.15
Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA (2010) 4.33
Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med (2014) 3.78
Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med (2008) 3.73
A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis. Am J Respir Crit Care Med (2013) 3.44
Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab (2008) 3.21
Bedside electronic capture of clinical observations and automated clinical alerts to improve compliance with an Early Warning Score protocol. Crit Care Resusc (2011) 2.89
Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature (2012) 2.83
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology (2004) 2.77
Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care (2002) 2.51
Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc (2010) 2.44
Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab (2006) 2.43
Preoxygenation is more effective in the 25 degrees head-up position than in the supine position in severely obese patients: a randomized controlled study. Anesthesiology (2005) 2.42
The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med (2011) 2.39
Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg (2013) 2.37
Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes (2010) 2.35
Arterial carbon dioxide tension and outcome in patients admitted to the intensive care unit after cardiac arrest. Resuscitation (2013) 2.32
The effect of rate of weight loss on long-term weight management: a randomised controlled trial. Lancet Diabetes Endocrinol (2014) 2.30
Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species. PLoS Pathog (2010) 2.18
Effectiveness and side effects of thiazolidinediones for type 2 diabetes: real-life experience from a tertiary hospital. Med J Aust (2004) 2.14
Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care (2009) 2.04
Carbon dioxide insufflation in open-chamber cardiac surgery: a double-blind, randomized clinical trial of neurocognitive effects. J Thorac Cardiovasc Surg (2012) 2.04
The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med (2011) 2.01
Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care (2009) 2.00
Sustained reduction in serious fall-related injuries in older people in hospital. Med J Aust (2006) 1.86
Ionized calcium concentration and outcome in critical illness. Crit Care Med (2011) 1.83
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nat Med (2011) 1.83
Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome: a retrospective international multicenter study. Crit Care Med (2015) 1.80
Depression in association with severe obesity: changes with weight loss. Arch Intern Med (2003) 1.80
Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry (2008) 1.78
Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care (2010) 1.77
Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys (2006) 1.75
Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection. J Immunol (2005) 1.69
Early goal-directed sedation versus standard sedation in mechanically ventilated critically ill patients: a pilot study*. Crit Care Med (2013) 1.67
The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg (2002) 1.64
Mortality related to after-hours discharge from intensive care in Australia and New Zealand, 2005-2012. Intensive Care Med (2014) 1.64
A controlled trial of electronic automated advisory vital signs monitoring in general hospital wards. Crit Care Med (2012) 1.63
Minimal reporting requirements for weight loss: current methods not ideal. Obes Surg (2005) 1.58
External ventricular drain infections are independent of drain duration: an argument against elective revision. J Neurosurg (2007) 1.57
Effect of selective inhibition of renal inducible nitric oxide synthase on renal blood flow and function in experimental hyperdynamic sepsis. Crit Care Med (2012) 1.56
Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multicentre cohort study. Intensive Care Med (2013) 1.56
Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care (2011) 1.55
Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial. Crit Care Med (2013) 1.52
Stress hyperlactatemia modifies the relationship between stress hyperglycemia and outcome: a retrospective observational study. Crit Care Med (2014) 1.52
Treatment limitations at admission to intensive care units in Australia and New Zealand: prevalence, outcomes, and resource use*. Crit Care Med (2012) 1.51
Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet. J Endocrinol (2005) 1.51
Accuracy of electrocardiogram interpretation improves with emergency medicine training. Emerg Med Australas (2007) 1.50
Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA (2012) 1.50
Prospective audit of parastomal hernia: prevalence and associated comorbidities. Dis Colon Rectum (2010) 1.48
The Association Between Low Admission Peak Plasma Creatinine Concentration and In-Hospital Mortality in Patients Admitted to Intensive Care in Australia and New Zealand. Crit Care Med (2016) 1.47
Does pregnancy increase the need for revisional surgery after laparoscopic adjustable gastric banding? Obes Surg (2011) 1.47
Nutritional therapy in patients with acute pancreatitis requiring critical care unit management: a prospective observational study in Australia and New Zealand. Crit Care Med (2011) 1.46
Sweet eating is not a predictor of outcome after Lap-Band placement. Can we finally bury the myth? Obes Surg (2002) 1.46
Total leukocyte control for elective coronary bypass surgery does not improve short-term outcome. Ann Thorac Surg (2005) 1.43
Prospective randomized controlled trial of operative rib fixation in traumatic flail chest. J Am Coll Surg (2013) 1.43
Small bowel obstruction creates a closed loop in patients with a laparoscopic adjustable gastric band. Obes Surg (2008) 1.41
Is an age-of-blood transfusion trial in trauma patients in Australia and New Zealand feasible? Crit Care Resusc (2013) 1.39
What causes post-traumatic empyema? Emerg Med Australas (2009) 1.38
Systematic review of erosion after laparoscopic adjustable gastric banding. Obes Surg (2011) 1.36
Public health campaigns and obesity - a critique. BMC Public Health (2011) 1.35
Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography. Chest (2003) 1.34
Loss of control is central to psychological disturbance associated with binge eating disorder. Obesity (Silver Spring) (2008) 1.34
Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study. Crit Care (2013) 1.33
A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg (2005) 1.32
Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. Obesity (Silver Spring) (2008) 1.31
Hunger control and regular physical activity facilitate weight loss after laparoscopic adjustable gastric banding. Obes Surg (2008) 1.31
Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med (2012) 1.29
Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab (2004) 1.28
Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg (2002) 1.28
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge. J Virol (2011) 1.28
Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab (2006) 1.27
Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice. BMC Complement Altern Med (2010) 1.27
Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr (2006) 1.26
Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer. Clin Cancer Res (2011) 1.26
Radical lymph node dissection for melanoma. ANZ J Surg (2003) 1.24
Pharmacotherapy for obesity. Drugs (2005) 1.24
Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. J Virol (2010) 1.22
Substantial intentional weight loss and mortality in the severely obese. Ann Surg (2007) 1.22
Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg (2006) 1.21
Early institution of mechanical support improves outcomes in primary cardiac allograft failure. J Heart Lung Transplant (2005) 1.20
Histological and biochemical analysis of mechanical and thermal bioeffects in boiling histotripsy lesions induced by high intensity focused ultrasound. Ultrasound Med Biol (2013) 1.20
Australasian resuscitation of sepsis evaluation (ARISE): A multi-centre, prospective, inception cohort study. Resuscitation (2009) 1.19